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Background: Hyal1 is a turnover enzyme for hyaluronan that accelerates metastatic cancer by increasing cell motility.
Results: Hyal1-overexpressing cells have a higher rate of endocytosis that impacts cargo internalization and recycling.
Conclusion: The higher rate of vesicle trafficking increases motility receptor function and nutrient uptake.
Significance: This novel mechanism implicates Hyal1 trafficking in multiple signaling events during tumor progression.
Hyaluronan (HA) turnover accelerates metastatic progression of prostate cancer in part by increasing rates of tumor cell
proliferation and motility. To determine the mechanism, we
overexpressed hyaluronidase 1 (Hyal1) as a fluorescent fusion
protein and examined its impact on endocytosis and vesicular
trafficking. Overexpression of Hyal1 led to increased rates of internalization of HA and the endocytic recycling marker transferrin.
Live imaging of Hyal1, sucrose gradient centrifugation, and specific
colocalization of Rab GTPases defined the subcellular distribution
of Hyal1 as early and late endosomes, lysosomes, and recycling vesicles. Manipulation of vesicular trafficking by chemical inhibitors
or with constitutively active and dominant negative Rab expression
constructs caused atypical localization of Hyal1. Using the catalytically inactive point mutant Hyal1-E131Q, we found that enzymatic activity of Hyal1 was necessary for normal localization within
the cell as Hyal1-E131Q was mainly detected within the endoplasmic reticulum. Expression of a HA-binding point mutant, Hyal1Y202F, revealed that secretion of Hyal1 and concurrent reuptake
from the extracellular space are critical for rapid HA internalization and cell proliferation. Overall, excess Hyal1 secretion accelerates endocytic vesicle trafficking in a substrate-dependent manner,
promoting aggressive tumor cell behavior.

Prostate cancer is the most frequently diagnosed cancer in
men (1). Aggressive and metastatic cancers reorganize and
invade local tissue matrix, which contributes to the enhanced
potential for survival and proliferation of tumor cells under
extreme conditions. Hyaluronan (HA)2 is an extracellular
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matrix glycosaminoglycan that consists of repeating disaccharides of glucuronic acid and N-acetylglucosamine. Turnover of
HA is controlled by activity of its degradation enzymes, the
hyaluronidases (Hyals), and its synthesis enzymes, the hyaluronan synthases (HASs). In humans, there are five isoforms of
Hyal, Hyal1– 4, and PH-20 and three isoforms of HAS, HAS1–3
(for a review, see Ref. 2). Altered expression profiles of the Hyal
and HAS proteins have been associated with many types of
cancers (3–7). Detection of elevated expression of Hyal1 and
concurrent accumulation of HA in biopsies are an indicator of
poor prognosis for prostate cancer (8). In a mouse orthotopic
model of prostate cancer, the accelerated turnover of HA
through overexpression of Hyal1 with or without concurrent
expression of HAS isozyme HAS2 or HAS3 increases prostate
tumorigenesis and metastatic frequency due in part to
enhanced tumor cell motility and cell cycle progression (9).
The mechanisms by which Hyal1 overexpression impacts
motility and proliferation of tumor cells are not fully understood. Notably, stable prostate tumor cell lines expressing
Hyal1 display altered surface expression of CD44, ␣4␤1 integrin, and N-cadherin, all of which are critical plasma membrane
receptors that transduce signals for adhesion, migration, and
proliferation (9 –11). HA-overproducing cells with low Hyal1
levels inappropriately sustain activation of ERK and elevation of
cyclin-dependent kinase inhibitors, which contribute to a delay
in cell cycle progression that is relieved by expression of Hyal1.
Moreover, because these cells have less plasma membrane
integrin and N-cadherin, restoration of normal receptor function in the presence of Hyal1 potentially contributes to accelerated proliferation and motility.
Interestingly, CD44, ␣4␤1 integrin, and N-cadherin have all
been shown to internalize via the same clathrin-independent
route (12) and re-externalize through vesicular sorting processes. It is also known that plasma membrane-associated HA
can be internalized from the extracellular matrix into the endocytic pathway (13) in a manner that is dependent on Hyal1 and
the cell surface HA receptor CD44 (14). Differential engagement of CD44 by HA polymers versus Hyal1-cleaved HA fragments or oligomers, respectively, sustains cellular quiescence
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or induces internalization of the complex. Treatment of tumor
cells with small HA oligomers induces disruption of CD44
complexes and subsequent internalization of CD44 (15). Similarly, treatment of breast cancer cells with HA oligomers causes
CD44 internalization and prevents efflux of lactate from the
cells (16). Conversely, it was shown that high molecular mass
HA (ⱖ1 million Da) inhibited the stimulation of cyclin D1, acting through the CD44 receptor (17).
The mechanism of Hyal1 enzyme secretion was recently
examined in murine macrophages, one of the cell types that is
most critically dependent on Hyal1 function. In these cells,
Hyal1 is secreted via the ER-Golgi pathway where only a small
portion of it is mannose 6-phosphorylated for lysosomal targeting (18). Rather, the majority of the protein is released to the
extracellular space and is thought to traffic to lysosomes via
endocytosis following capture by the cell surface mannose
receptor. Enzyme function has been extensively characterized
in vitro using site-directed mutagenesis and hyaluronidase
enzyme kinetics, but the impact of Hyal1 and its functional
mutants on vesicle and receptor trafficking in the context of
growth and motility has not been examined. Hyal1 is an acidactive endolytic glycosidase that acts on HA or chondroitin
sulfate polymers. Glutamate 131 of Hyal1 is a conserved active
site residue that serves as a general acid/general base for hydrolytic cleavage of the ␤-1,4 linkage between N-acetylglucosamine and glucuronate. Mutation of this residue to a glutamine (E131Q) results in complete loss of hyaluronidase activity
(19). An additional mutant substituting tyrosine 202 with phenylalanine (Y202F) produces a less impaired enzyme with significantly reduced affinity for HA, although it is still catalytically competent if the substrate is saturating. Hyal1E131Q and
Hyal1Y202F are thought to be processed and secreted similarly
to wild-type Hyal1 based on Western analysis of lysates and
conditioned media (19). In this study, we utilized these point
mutants to determine whether the phenotypic effects of Hyal1
overexpression in prostate cancer cells are dependent on its
catalytic activity and/or ability to bind extracellular substrates.
Because Hyal1 expression is functionally linked to accelerated proliferation and migration, we investigated the molecular
mechanisms by which Hyal1 overexpression directly impacts
these processes in the tumor cells. In the current study, we
hypothesized that elevated Hyal1 could be affecting cell surface
receptor function through alterations in endocytic turnover
and vesicle sorting in the cell. To test this, we generated cell
lines expressing Hyal1 or its point mutants as fluorescent fusion
proteins and characterized growth, motility, and the trafficking
itinerary of Hyal1 within live cells. In the context of a well established prostate cancer model where HA homeostasis has a profound impact on cancer progression, these studies provide
mechanistic insights into Hyal1 function in cancer that are distinct from its function in normal macrophages and other cells.

Experimental Procedures
Reagents and Antibodies—Fluorescein-conjugated HA was
purchased from Merck Millipore. Transferrin-Alexa Fluor 633
conjugate, anti-transferrin receptor antibody, LysoTracker
Green DND-26, and ER-Tracker Green BODIPY FL glibenclamide were purchased from Life Technologies. Brefeldin A,
MAY 22, 2015 • VOLUME 290 • NUMBER 21

chloroquine diphosphate salt, and bafilomycin A1 were
obtained from Sigma-Aldrich. Anti-Hyal1 rabbit polyclonal
was raised against recombinant Hyal1 protein purified from
HEK293 conditioned medium and was previously characterized by our laboratory (19). Anti-calnexin and anti-EEA1 were
from BD Biosciences, and anti-cathepsin D was from Calbiochem. Secondary antibodies were goat anti-rabbit IRDye800
and donkey anti-mouse IRDye800, both purchased from Rockland Immunochemicals (Limerick, PA). Other reagents were
obtained from Fisher Scientific except where indicated.
Cell Culture and Stable Cell Selection—22Rv1 human prostate adenocarcinoma cells were purchased from ATCC
(Manassas, VA) and grown in RPMI 1640 medium containing
10% FBS. Culture of 22Rv1 stable transfectants expressing
pIRES2-EGFP vector or the constructs encoding unfused
Hyal1WT and Hyal1E131Q was as described previously (9, 10).
The ptdTomato-N1 vector was purchased from Clontech and
was used to create constructs encoding the wild-type Hyal1 and
point mutants E131Q and Y202F fused to the N terminus of the
tdTomato fluorescent reporter protein (excitation, 554 nm;
emission, 581 nm). Following sequence verification, empty vector control (tdTomato (tdT)) and the Hyal1WT-tdT,
Hyal1Y202F-tdT, and Hyal1E131Q-tdT constructs were used
to transfect 22Rv1 cells via the liposomal reagent FuGENE HD
(Promega, Madison, WI). Red fluorescent stable lines were
selected from resultant colonies following growth in standard
serum-containing medium supplemented with 1.5 mg/ml
G418. Expression of tdTomato and Hyal1 fusion proteins was
assessed by Western analysis using our rabbit polyclonal antiHyal1 antibody and anti-dsRed antibody (Clontech). Three to
five lines per construct were selected to express equivalent total
Hyal1 fusion protein (data not shown). All stable lines were
subsequently maintained in RPMI 1640 medium containing
10% FBS and 1.5 mg/ml G418.
Protein Expression Analysis—An initial comparison of fusion
protein expression among stable cell lines was made by Western analysis of crude fractions. Cells were seeded to achieve 70%
confluence in 48 h of culture using standard medium with 2%
low IgG-containing serum. Conditioned media were removed
and concentrated 10-fold for non-reducing Western blotting.
Cells were washed with PBS, trypsin-released, pelleted at
1000 ⫻ g, washed once with PBS, resuspended in PBS containing protease inhibitors, and centrifuged at 15,000 ⫻ g (15 min at
4 °C). The supernatant was collected as the cytosolic fraction.
The pellet was resuspended in PBS with 1% Triton and protease
inhibitor mixture, incubated on ice (30 min), and then cleared
by centrifugation at 15,000 ⫻ g (10 min at 4 °C). This supernatant was removed as the membrane- and organelle-enriched
fraction.
After gel electrophoresis, proteins were transferred to a
PVDF membrane. Membranes were blocked with 5% milk in
PBS ⫹ 0.1% Tween and probed with anti-Hyal1 rabbit polyclonal (1:1000) or anti-tubulin (1:750,000). After primary incubation, membranes were washed, incubated with IRDye-conjugated secondary antibodies, and then imaged using the LI-COR
Odyssey and software.
Proliferation and Motility Assays—To compare rates of proliferation, equal numbers of cells from each of the four stable
JOURNAL OF BIOLOGICAL CHEMISTRY
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tdTomato cell line populations as indicated were seeded in
quadruplicate wells of five 96-well plates (3 ⫻ 104 cells/ml in
100 l of serum-containing medium/well). Each day, one set of
quadruplicate wells per line was trypsin-released, neutralized,
and manually counted in a hemacytometer. Mean cell counts
per well were plotted from one representative 5-day assay that
was reproduced at least three times. Cells expressing unfused
Hyal1WT or Hyal1E131Q in the pIRES2-EGFP vector were
assayed similarly but quantified by addition of WST-1 reagent,
plotting absorbance at 450 nm. Statistical significance was
assessed using Student’s two-tailed t test.
Motility was measured using a 48-well modified Boyden chemotaxis chamber. Lower wells were loaded with serum-free
medium containing 25 g/ml type IV mouse collagen (BD Biosciences). The upper wells were filled with serum-free medium
containing single cell suspensions of each stable line in quadruplicate as indicated (2 ⫻ 104 cells) separated from the lower
wells by polycarbonate membranes with 8-m pore size (Neuroprobe Inc., Gaithersburg, MD). After incubating at 37 °C for
21 h, the membrane was removed from the chamber, fixed,
stained with the Diff-Quik Stain kit (VWR International, Batavia, IL), and mounted on a glass slide. Unmigrated cells were
removed from the top of the membrane with a cotton swab, and
the membrane was preserved with Gel Mount and a glass coverslip. Migrated cells were counted in five random fields per
well at 20⫻ magnification using a gridded ocular micrometer.
Representative data were plotted from an assay reproduced at
least three times. Significance was determined by Student’s t
test.
Characterization of Hyal1 Subcellular Localization and Trafficking Itinerary—Cells were seeded in glass bottom culture
dishes (MatTek Corp., Ashland, MA) for 24 h prior to imaging
or treatment. At 24 h postseeding, live cells were washed with
fresh medium and immediately imaged on an Olympus FV500
confocal laser scanning microscope with an Olympus IX81
inverted fluorescence microscope and an Olympus PlanApo
100⫻ oil lens (numerical aperture, 1.45; working distance, 17
mm). To demonstrate subcellular localization of the tdTomato
fusion proteins, we incubated cells with live dye tracking agents
before washing and imaging. LysoTracker Green DND-26 was
used at a concentration of 75 nM for 5 min at 37 °C. ER-Tracker
Green BODIPY FL glibenclamide was used at a concentration
of 1 M for 20 min. Imaging of colocalization was performed
using a Marianas microscopy system with a Plan-NEOFLUAR
40⫻, 1.3 numerical aperture objective controlled by SlideBook
5.0 image acquisition software (Intelligent Imaging Innovations
Inc., Denver, CO). Colocalization of fluorescent proteins was
quantified by importing images (n ⫽ 10 –16) into ImageJ and
calculating the Pearson’s correlation coefficient for the green
channel signal overlaid on the tdTomato signal.
To perturb intracellular trafficking and confirm subcellular
localization of Hyal1 fusion proteins, we incubated cells preseeded in glass bottom dishes with specific trafficking inhibitors for the times indicated, washed, and then imaged immediately on the Olympus FV500-IX81 confocal microscope.
Brefeldin A was used at a concentration of 10 g/ml for 1 h at
37 °C. Chloroquine diphosphate salt was used at a concentra-
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tion of 50 M for 24 h at 37 °C. Bafilomycin A1 was used at a
concentration of 5 nM for 48 h at 37 °C.
Biochemical Fractionation and Western Analysis—Stable
transfectants expressing Hyal1WT-tdT, Hyal1Y202F-tdT, or
Hyal1E131Q-tdT were incubated in standard medium or
treated as above in brefeldin A, chloroquine, or bafilomycin A1.
After desired treatments, cells were washed with PBS, scraped
off the culture dish, pelleted at 1500 rpm, and resuspended in
0.5 ml of PBS. Cells were lysed by drawing through a 21-gauge
needle 20 times. Lysed cells were centrifuged at 800 ⫻ g for 10
min at 4 °C to pellet the insoluble fraction. The postnuclear
supernatant was then applied to the top of a tube containing a
continuous sucrose gradient from 10 to 40% sucrose. The gradient was centrifuged for 6 h at 100,000 ⫻ g at 4 °C. Fractions of
250 l each were collected by piercing the bottom of the tube
with a needle and allowing the fractions to drip out.
After gel electrophoresis, proteins were transferred to a
PVDF membrane. Membranes were blocked with 5% milk in
PBS ⫹ 0.1% Tween and probed with desired antibodies. Primary antibody dilutions used were as follows: anti-Hyal1 rabbit
polyclonal (1:1000), anti-calnexin (1:2000), anti-cathepsin D
(2.5 g/ml), and anti-EEA1 (1:250). After primary incubation,
membranes were washed and incubated with IRDye-conjugated secondary antibodies. Membranes were imaged using the
LI-COR Odyssey and software.
Rab Colocalization—Stable Hyal1WT-tdT transfectants
were transiently transfected with constructs expressing C-terminal GFP fusions with Rab5, Rab7, Rab11, or their constitutively active or dominant negative counterparts. After 48 h, live
cells were imaged on the Olympus FV500-IX81 confocal microscope. Colocalization of fluorescent proteins was quantified by
importing images into ImageJ and calculating the Pearson’s
correlation coefficient for the GFP signal overlaid on the
tdTomato signal.
Fluorescein-HA Uptake—Stable transfectant lines were
seeded in glass bottom dishes overnight, washed in serum-free
medium, and incubated for 5 min in 100 nM fluorescein-conjugated HA (fHA) prior to imaging on the Olympus FV500-IX81
confocal microscope. To quantify the impact of HA uptake on
Hyal1 distribution, images were imported into ImageJ, and
Pearson’s correlation coefficient was calculated for HA in green
relative to Hyal1 in red. To determine whether secreted Hyal1
was essential for HA uptake, we treated cell lines with brefeldin
A for 1 h to suppress ER-Golgi secretion of Hyal1 and repeated
the 5-min fHA treatment. Finally, to determine whether Hyal1
HA binding or catalytic activity was essential for HA endosomal
internalization, we allowed brefeldin A-treated cells to recover
for 30 min and again assayed HA internalization and repeated
the image collection and calculation of correlation coefficients.
Transferrin Uptake—Cells were seeded overnight in 10-cm
tissue culture dishes, washed in serum-free media, and incubated with transferrin-Alexa Fluor 633 conjugate for the indicated periods of time. Following incubation, cells were washed
twice with PBS, released with trypsin, washed twice, and resuspended in PBS for immediate analysis by flow cytometry. Mean
fluorescence intensity of the Alexa Fluor 633 signal for the scatter-gated cells was plotted for the uptake time course to illustrate differences among cells.
VOLUME 290 • NUMBER 21 • MAY 22, 2015
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Results
Hyal1 Increases Proliferation and Motility of Prostate Tumor
Cells by a Mechanism That Requires Its Catalytic Competence—We previously reported that 22Rv1 human prostate carcinoma cells selected for stable overexpression of Hyal1 exhibited higher motility and proliferation relative to control lines
expressing only the empty vector (9). Of note, cells with high
levels of Hyal1 expression also had greater cell surface expression of ␤1 integrin and N-cadherin and were more adherent to
extracellular matrix proteins such as fibronectin and collagen
(11). To further examine the mechanism of Hyal1 impact on
cellular function, we selected cells that stably expressed
wild-type Hyal1, the reduced HA-binding mutant Hyal1Y202F, or its catalytically inactive point mutant, Hyal1E131Q (19), as an N-terminal fusion to the tdTomato fluorescent protein encoded with the native N-terminal Hyal1 signal
peptide (hereafter referred to as Hyal1WT-tdT, Hyal1Y202FtdT, and Hyal1E131Q-tdT, respectively). All three fusion proteins were expressed and folded correctly based on the detection of comparable levels in conditioned media and strong
expression in lysates (Fig. 1A) relative to the distribution profiles of unfused proteins in our previous study (19). Although all
three proteins were secreted, subdivision of whole cell lysates
into cytosolic and Triton-soluble membrane/organelle-enriched fractions prior to Western analysis revealed all three in
the Triton-soluble fractions and minimally cytosolic as previously observed for the unfused proteins. However, similar
expression of Hyal1E131Q-tdT in conditioned media relative
to the wild-type or Y202F fusions was attained only when lysate
levels of the Hyal1E131Q-tdT stable lines were ⬇10-fold
higher.
As expected, stable Hyal1WT-tdT cells grew and migrated
more rapidly than the control vector transfectant (Fig. 1B). In
contrast, cells overexpressing Hyal1E131Q-tdT did not exhibit
accelerated growth or motility (Fig. 1C), achieving rates of proliferation and migration that were comparable with those of the
empty vector transfectants. These results were consistent with
relative proliferation and motility of stable transfectants overexpressing Hyal1WT or Hyal1E131Q native proteins with GFP
as a reporter but not as a fusion protein (Fig. 1, D and E, respectively). Interestingly, the proliferation and migration rates of
Hyal1Y202F-tdT cells were enhanced relative to the empty vector controls but not to the extent conferred by overexpression
of Hyal1WT-tdT. Thus, the catalytic activity of overexpressed
Hyal1 is at least partially responsible for the higher rates of cell
growth and migration in 22Rv1 prostate tumor cells, and the
effect is potentially dependent on Hyal1 binding efficiency
and/or external substrate concentrations.
Vesicular Localization of Hyal1 in Prostate Tumor Cells Is
Dependent upon Its Catalytic Activity—We hypothesized that
the rate or itinerary of Hyal1 vesicular trafficking may be dictated by its catalytic competence and/or substrate binding
potential, which in turn could generally impact cell behavior
through the alterations in cell surface integrin and cadherin we
showed previously (9 –11). Because Hyal1 is important for
internalization and lysosomal breakdown of HA, we chose to
use the tdTomato fusion as a reporter for studies investigating
MAY 22, 2015 • VOLUME 290 • NUMBER 21

FIGURE 1. Expression of catalytically active Hyal1 increases proliferation and motility of prostate tumor cells. 22Rv1 prostate carcinoma
cells were selected for stable overexpression of the empty vector encoding the reporter tdT or the wild-type Hyal1 (WT and Hyal1WT-tdT),
Hyal1Y202F, or Hyal1E131Q, each as a fusion with tdT. A, soluble cell lysates,
membrane-enriched fractions, and concentrated conditioned media were
analyzed by Western blotting with equal amounts of total protein probed for
Hyal1 (fusion protein molecular mass of ⬇100 kDa) and normalized to tubulin. The specific band for Hyal1-tdT fusion protein in conditioned media is
indicated by an arrowhead. B, proliferation was assayed by daily manual
counts. Equal numbers of cells were seeded in quadruplicate wells of 96-well
plates. Cell numbers are plotted as mean ⫾ S.D. (error bars). C, cell motility was
compared using a modified Boyden chamber assay. Lower wells contained
type IV collagen as a chemotactic agent. Single cell suspensions were placed
in the upper wells separated from the lower wells by a polycarbonate membrane with 8-m pore size. The mean ⫾ S.D. (error bars) is plotted for quadruplicate manual counts per cell line. D and E, proliferation and motility,
respectively, were quantified for 22Rv1 cells stably expressing empty vector
(pIRES2-EGFP), Hyal1WT, or Hyal1E131Q unfused proteins as indicated. *, p ⬍
0.01 for Hyal1WT-tdT transfectant values relative to those of the tdT control
line. MWM, molecular weight markers; IB, immunoblot.

the trafficking of Hyal1 within the cell because of the superior
pH stability of its fluorescence signal. Examination of the 22Rv1
transfectants by confocal fluorescence microscopy revealed
that Hyal1WT-tdT localized within structures resembling
endocytic and/or lysosomal vesicles (Fig. 2A). Similar results
were obtained for the Hyal1Y202F-tdT mutant (Fig. 2B),
which retains catalytic competence but requires ⬇5-fold higher
HA concentrations for maximal activity. In contrast, the
Hyal1E131Q-tdTomato protein appeared diffusely in the cytoplasm in a networked structure suggestive of ER localization
(Fig. 2C). The control tdTomato was distributed throughout
the cytoplasm and nucleus (Fig. 2D). In some cases, Hyal1WTtdT could be seen associated with focal contacts at the cell surface, a phenomenon that was not seen in the tdTomato or
Hyal1E131Q-tdT transfectants. These results indicate that the
catalytic activity of Hyal1 affects its localization within the cell.
Specifically, the distribution of Hyal1 coincided more promiJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Subcellular distribution of Hyal1 is affected by its catalytic competence. Stable 22Rv1 cell lines expressing an empty vector encoding the
tdTomato fluorescent reporter or C-terminal fusion constructs of tdTomato with wild-type or mutant Hyal1 were imaged by live cell confocal fluorescence
microscopy. Red fluorescence (left panel of each set) indicates localization of Hyal1WT-tdT fusion protein (A), Hyal1Y202F-tdT (B), Hyal1E131Q-tdT (C), or
tdTomato protein (empty vector; D). Inset panels are zoomed images of the individual cells designated by a corresponding white square. In the right panels of
each set, red channel fluorescence is superimposed on the corresponding transmitted light image. Scale bars, 10 m.

nently with the ER and minimally in endocytic vesicles when
the catalytic activity was abolished with no evidence of cell surface or internal punctate structures. These observations support a specific requirement for Hyal1 catalytic activity both in
normal secretion of Hyal1 protein by the cell and in the intracellular compartmentalization of the Hyal1 enzyme.
Catalytically Active Hyal1 Is Found in Vesicular Compartments That Localize with Lysosomal and Endosomal Markers—
We further examined Hyal1 fusion proteins in combination
with live cell organelle tracking dyes. Imaging of cells stained
with LysoTracker Green revealed partial overlap of Hyal1WTtdT fluorescence with the green lysosomal signal represented in
yellow (Fig. 3A; Pearson’s correlation coefficients are shown in
Fig. 3F). There was no detectable merge of Hyal1WT-tdT signal
with fluorescent green ER-Tracker (Fig. 3B). Similar results
were obtained with the Hyal1Y202F-tdT-transfected cells (Fig.
3, C, D, and F). In contrast, red staining of the Hyal1E131Q-tdT
fusion protein partially colocalized with green ER-Tracker (yellow areas) but not significantly with LysoTracker (Fig. 3E and
not shown). Strong overlap of signals is shown quantitatively by
calculation of Pearson’s coefficients for Hyal1WT-tdT (r ⫽
0.68 ⫾ 0.05) and Hyal1Y202F-tdT (r ⫽ 0.67 ⫾ 0.07) with LysoTracker and Hyal1E131Q-tdT (r ⫽ 0.75 ⫾ 0.04) with ERTracker (Fig. 3F). To confirm the subcellular compartmentalization of Hyal1WT and mutant enzymes, we performed
sucrose density gradient centrifugation of the three cell lines
and analyzed the resultant fractions by Western blotting (Fig.
3G). Hyal1 has been shown previously to be expressed as a single polypeptide of ⬃52 kDa in its constitutively secreted form
that is endosomally reinternalized in a clathrin-dependent
manner and subsequently becomes proteolyzed into two bands
of 52 and 48 kDa as vesicles mature to acidified lysosomes.
Consistent with this observation, we find that polyclonal Hyal1
antibodies detect two bands for the Hyal1 fusion protein that
are separated by an ⬇4-kDa molecular mass difference
(observed in Hyal1WT and both mutant Western fractions;
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Figs. 3G and 4, G and H). The Hyal1 band consistent with the
intact secreted mass of Hyal1-tdT is ⬃100 kDa and can be
observed to co-fractionate in all three cell lines with EEA1 (fractions 4 – 6), cathepsin D (two bands; fractions 13–17), and calnexin (fractions 13–19), which correspond to fractions of early
endosomes, lysosomes, and microsomes (ER), respectively.
However, close comparison of the fractions reveals a greater
portion of uncleaved enzyme species in the Hyal1E131Q-tdT
cell line that specifically extends throughout the denser fractions (fractions 14 –19) of the sucrose gradient in contrast to
the wild-type and Y202F mutant, which are more similar to the
profile of cathepsin D fractions (fractions 13–17). These results
support an active role in vesicular trafficking by catalytically
active Hyal1 cargo. The partial unique localization of Hyal1 to
non-lysosomal vesicles is consistent with its presence in early or
late endosomes in transit from the plasma membrane.
Active Hyal1 Protein Is Secreted via the ER-Golgi Pathway
and Endosomally Reinternalized—To elucidate the trafficking
itinerary of Hyal1 within the cell, we chemically manipulated
commonly used trafficking pathways. First, brefeldin A was
used to inhibit protein movement from the ER to the Golgi (20).
As a positive control, 22Rv1 cells treated with and without
brefeldin A were fixed, permeabilized, and stained with antitransferrin receptor. Treatment with brefeldin A caused a dramatic visual shift in transferrin receptor localization from primarily punctate structures to a more dense and centralized
staining pattern consistent with perinuclear ER networks, suggesting that the trafficking to the Golgi has been inhibited (not
shown). When the same treatment was used on 22Rv1 stable
lines expressing Hyal1WT-tdT, no difference was seen with or
without brefeldin A (Fig. 4, A, B, and E). Similarly, sucrose gradient fractionation of Hyal1WT-tdT cells after brefeldin A
treatment showed no shift in localization compared with
untreated cells (Fig. 4G). Cells expressing Hyal1Y202F-tdT
bore a similar punctate intracellular appearance to the
Hyal1WT-tdT cells with an overall greater indication of diffuse
VOLUME 290 • NUMBER 21 • MAY 22, 2015
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fluorescence upon brefeldin A treatment suggestive of some ER
accumulation of the fusion protein, whereas Hyal1E131Q-tdT
did not show a significant change in localization because this
protein was already primarily localized to the ER (Fig. 4, A, B,
and F). However, the ER-localized signal was slightly more
intense in the presence of brefeldin A treatment. Although
there was no obvious shift of the Hyal1E131Q-tdT protein into
the denser fractions of the sucrose gradients after brefeldin A
treatment (Fig. 4H), there was increased intensity of the higher
molecular mass band in all fractions, consistent with accumulation of the canonical secretion product. Thus, the inactive
mutant fusion protein is likely secreted by this pathway but at a
slower rate than the wild type. These results indicate that the
normal trafficking mechanism for internalized Hyal1 protein
includes trafficking from the ER to the Golgi that is dependent
upon the catalytic activity and/or substrate affinity of Hyal1.
Inhibition of Lysosomal Acidification Causes Buildup of
Hyal1 Wild-type Protein—To further assess a lysosomal destination for Hyal1, we treated the 22Rv1 stable lines with chloroquine, which inhibits maturation of lysosomes by preventing
acidification (21). Chloroquine treatment of either Hyal1WTtdT or Hyal1Y202F-tdT transfectants resulted in accumulation
of larger sized red channel vesicles (Fig. 4, C, E, and F). Sucrose
gradient fractionation confirmed that chloroquine treatment
induced a shift in the content of Hyal1WT-tdT (fractions
12–17 in Fig. 4G) to higher density fractions (fractions 13–19)
as well as a small portion localized to the least dense fractions 4
and 6. Moreover, the lower molecular mass band decreased in
intensity, consistent with reduced cleavage of Hyal1 as occurs
in acidified vesicles. These results suggest that Hyal1 was prevented from following its normal trafficking itinerary to lysosomes where it would function to degrade HA and other
glycosaminoglycans and is itself subject to proteolysis. Chloroquine treatment of the 22Rv1 Hyal1E131Q-tdT cells did not
alter the fluorescence distribution because significantly lower
amounts of the inactive mutant are in vesicles (Fig. 4C). However, there was reduced Hyal1 fusion protein in all fractions,
and in particular, the lower molecular mass band associated
with lysosomal activation was absent (Fig. 4H).
Hyal1 Intracellular Trafficking Overlaps with Autophagic
Vesicle Formation—To determine whether vesicles containing
Hyal1 were involved in autophagy, we treated 22Rv1 stable lines
with bafilomycin A1, which prevents the fusion of autophagosomes with lysosomes by inhibiting the vacuolar ATPase that
acidifies these vesicles during their maturation (22, 23). When
22Rv1 Hyal1WT-tdT or Hyal1Y202F-tdT cells were treated

FIGURE 3. Characterization of intracellular Hyal1 distribution by confocal
microscopy and biochemical fractionation. A–F, still images of live 22Rv1
cells expressing Hyal1WT-tdT (A and B), Hyal1Y202F-tdT (C and D), or
Hyal1E131Q-tdT (E) were captured by confocal microscopy following treatment with either LysoTracker Green DND-26 (A and C) or ER-Tracker Green
BODIPY FL glibenclamide (B, D, and E). Yellow color represents colocalization
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of signals. Strong colocalization of Hyal1WT-tdT and Hyal1Y202F-tdT was
observed with LysoTracker Green (Lyso), whereas the Hyal1-E131Q-tdT
merged with ER-Tracker Green (ER) as indicated by Pearson’s correlation coefficient (F). Error bars indicate S.E. G, stable 22Rv1 transfectants expressing
Hyal1WT-tdT or Hyal1E131Q-tdT were lysed and fractionated on a continuous
sucrose gradient. Fractions were collected and analyzed by Western blotting
with anti-Hyal1 polyclonal antibody. Blots were stripped and reprobed with
antibodies to cathepsin D (lysosomes), calnexin (ER), and EEA1 (early endosomes). In each panel, MWM is the molecular weight marker, 800⫻g is the
insoluble fraction of the cell lysate, and PNS indicates a sample of the postnuclear supernatant (soluble lysate) that was loaded on the gradient. Numbers correspond to the density fraction following centrifugation. Increasing
numbers indicate increasing density. Scale bars, 10 m.
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FIGURE 4. Examination of Hyal1 trafficking itineraries by chemical inhibition of vesicular transport or vesicle acidification. A–D, stable 22Rv1 cell
lines expressing Hyal1-tdTomato fusions were incubated in the absence (row A) or presence of brefeldin A (BFA) (row B), chloroquine (Chl) (row C), or
bafilomycin A1 (BafA1) (row D). Representative images of cells are shown from cultures of Hyal1WT-tdT (left column), Hyal1Y202F-tdT (center column),
and Hyal1E131Q-tdT (right column). Inset panels show magnified images of individual cells designated in white squares. Images are presented with red
channel fluorescence isolated in black and white to increase sensitivity of visualization and facilitate analysis. Average vesicle sizes for Hyal1WT-tdT (E)
and Hyal1Y202F-tdT (F) were quantified and compared in each condition. Error bars indicate S.E. Statistical significance is indicated on the graphs.
Hyal1WT-tdT (G) and Hyal1E131Q-tdT (H) cells were cultured in standard media or the indicated inhibitor, then lysed, and fractionated by centrifugation
on a continuous sucrose gradient. In each panel, MWM is the molecular weight marker, 800⫻g is the insoluble fraction of the cell lysate, and PNS
indicates a sample of the postnuclear supernatant (soluble lysate) that was loaded on the gradient. Numbers correspond to fractions of increasing
density following centrifugation. Fractions were analyzed by Western blotting with the polyclonal anti-Hyal1 antibody. Arrows indicate bands corresponding to the full-length (black) and processed (red) forms of Hyal1.

with bafilomycin A1, there was a significant increase in the size
of Hyal1-positive vesicles within the cell (Fig. 4D). In the case of
Hyal1Y202F-tdT, the substrate-binding mutant, there was a
large decrease (54 ⫾ 5%, p ⬍ 0.001; data not shown) in the
number of vesicles per cell. Bafilomycin A1 treatment also
caused an accumulation of the unprocessed higher molecular
mass Hyal1WT-tdT protein in more dense sucrose gradient
fractions 16 –19 and in the least dense fractions 4 and 6 (Fig.
4G). This suggests that the autophagosomes and lysosomes
containing Hyal1 no longer fuse. As expected, bafilomycin A1
treatment had no effect on the fluorescence pattern of
Hyal1E131Q-tdT (Fig. 4D). However, the fusion protein is significantly reduced in all fractions of the gradient, and only the
uncleaved higher molecular mass species is present, primarily in endosomal fractions 4 and 6. Collectively, results are
consistent with internalized Hyal1 being directed partially to
lysosomes, a portion of which subsequently contribute to
autophagic turnover and autophagosome maturation.
Colocalization of Hyal1 with Rab GTPases Demonstrates Its
Presence during Endocytosis and Slow Recycling as Well as Late
Endosome to Lysosome Maturation—To further characterize
the trafficking itinerary of Hyal1, we transiently transfected sta-
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ble Hyal1WT-tdT cells with constructs encoding GFP fusions
to specific Rab GTPases that regulate the sorting of intracellular
vesicles. Based on the results of sucrose fractionation, we chose
to test Rab5 to identify early endosomes, Rab7 to mark late
endosomes and lysosomes, and Rab11 to visualize recycling
vesicles. Hyal1WT-tdT red fluorescence overlapped strongly
with signals from Rab5-GFP (Fig. 5, A and D; Pearson’s coefficient r ⫽ 0.51 ⫾ 0.14) and Rab7-GFP (Fig. 5, B and D; r ⫽ 0.68 ⫾
0.08), indicating a significant presence of Hyal1 in early endosomes, late endosomes, and lysosomes. Some signal overlap was
also observed with Rab11-GFP (Fig. 5, C and D; r ⫽ 0.31 ⫾ 0.11),
which suggests that a portion of Hyal1 is sorted to recycling
vesicles that return cargo to the cell surface and/or release it to
the extracellular space. We next sought to test the effects of
perturbing vesicle sorting on Hyal1 localization using previously characterized constitutively active or dominant negative
point mutants of each Rab-GFP fusion. Both constitutive activation of Rab5 and dominant negative Rab7 prevent conversion
of late endosomes to lysosomes. In each of these images, there is
an increased presence of colocalized signal in punctate structures, including several instances in which there appears to be
luminal red Hyal1 fluorescence encircled by green Rab5 or
VOLUME 290 • NUMBER 21 • MAY 22, 2015
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FIGURE 5. Colocalization of wild-type Hyal1 with Rab GTPases demonstrates its presence in endocytic and slow recycling vesicles as well as late
endosomes and lysosomes. Stable Hyal1WT-tdT cells were transfected with constructs encoding GFP fusions to Rab5, Rab7, or Rab11. Colocalization of each
Rab protein is shown by confocal imaging of Rab-GFP fusions (green) and Hyal1-tdT fusions (red) for Rab5 (A), Rab7 (B), and Rab11 (C). Yellow color indicates
colocalization. Each set of images shows colocalization of wild-type Rab (left column), constitutively active (CA) Rab (center column), or dominant negative (DN)
Rab (right column). Inset panels are magnified images of individual cells indicated by white squares. D, colocalization of Hyal1WT-tdT with each Rab-GFP
construct was quantified by Pearson’s coefficient and plotted as mean ⫾ S.E. (error bars). Scale bars, 10 m.

Rab7 fluorescence. This is further evidence of endosomally
internalized Hyal1 being trafficked from early to late endosomes, ultimately maturing to lysosomes. Dominant negative
Rab11, which contributes to the arrest and accumulation of
recycling vesicles, showed increased colocalization with
Hyal1WT-tdT relative to wild-type Rab11, which supports the
slow recycling of a portion of Hyal1 back to the cell surface for
re-externalization.
Hyaluronan Uptake Requires Catalytically Active Hyal1, and
Internalized HA Vesicles Colocalize with Hyal1—We next
wanted to examine the effect of exogenous substrate presence
on intracellular Hyal1-tdT distribution because extracellular
MAY 22, 2015 • VOLUME 290 • NUMBER 21

HA has been shown to internalize via endocytosis in a manner
dependent upon Hyal1 (14). Addition of fHA to the culture
media of Hyal1WT-tdT and Hyal1Y202F-tdT for 5 min followed by fluorescence confocal microscopy imaging produced
significant green fluorescent puncta indicative of endosomal
HA uptake (Fig. 6, A and B). This signal merged with red fluorescent tdT puncta as quantified by Pearson’s correlation coefficient, indicating colocalization of HA and Hyal1. In contrast,
no evidence of fHA uptake was detected in any images of
Hyal1E131Q-tdT or empty vector tdT transfectants (Fig. 6, C
and D). Thus, not only is expression of Hyal1 necessary for HA
internalization as shown previously, but these data show that
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Hyaluronan internalization requires catalytically active Hyal1, and internalized HA vesicles colocalize with Hyal1. Confocal images are shown
for uptake of fHA (green) by prostate tumor cells stably expressing Hyal1WT-tdT (A), Hyal1Y202F-tdT (B), Hyal1E131Q-tdT (C), or empty vector (D; tdTomato). Left
panels show fHA uptake alone in green, and right panels are the corresponding merge. Inset panels are magnified images of individual cells designated by white
squares in the merged panels. Scale bars, 10 m.

the internalized vesicular HA is coincident with Hyal1-positive
vesicles.
Extracellular Hyal1 Secretion Is Required for HA Internalization—Hyal1 enzymatic activity appeared to be required for
HA uptake (Fig. 6), but the altered secretion profile of the
Hyal1E131Q-tdT mutant relative to the wild-type enzyme
could also be a factor in the failure of the mutant Hyal1-expressing cells to internalize HA. To distinguish between these
possibilities, we re-examined HA uptake following a 1-h treatment of cells with brefeldin A to block secretion of Hyal1 protein from the cell. The treatment was either immediately followed by addition of fHA to the culture media and subsequent
image collection or by a 30-min recovery period prior to addition of fHA and image capture. Comparison of fHA (left inset
panels) and Hyal1-tdT (right inset panels) signal patterns in
brefeldin A-treated cells relative to untreated cells (Fig. 7, A and
B) reveals significantly reduced uptake of HA in both
Hyal1WT-tdT and Hyal1Y202F-tdt transfectants, although
tdT signal intensity and distribution do not appear to change,
consistent with distribution patterns in Figs. 4 and 6. Also
as expected, HA was not internalized in any condition by
Hyal1E131Q-tdT transfectants, nor was distribution of the tdT
fluorescence altered from its networked appearance. However,
after a short recovery period following brefeldin A treatment,
significantly increased numbers of small internal puncta in
which fHA and tdT fluorescence are merged could be seen in
Hyal1WT-tdT transfectants relative to the Hyal1Y202F-tdT
HA-binding mutants (Fig. 7C). These results (quantified in Fig.
7D) confirm that the concurrent uptake of HA and Hyal1 from
the extracellular space is required for Hyal1 internalization and
provide the novel indication that ligand binding to Hyal1 is a
critical prerequisite for uptake.
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Stable Hyal1 Expression Increases Rates of Endocytic HA
Uptake and Transferrin Internalization by Prostate Tumor
Cells—Finally, we evaluated whether the rate of HA uptake and
the overall rate of endocytosis differed in the 22Rv1 stable lines.
To do this, we incubated single cell suspensions with subsaturating fHA concentrations and monitored the time-dependent
fluorescence increase in the cell population by flow cytometry.
Consistent with the confocal microscopy data, Hyal1E131QtdT and tdTomato control transfectants did not appreciably
internalize fHA at any time point. However, cells expressing
Hyal1WT-tdT or Hyal1Y202F-tdT internalized HA to an equal
extent with similar rates of uptake. Loss of the fluorescein signal
occurred rapidly (within 15 min) in the Hyal1WT-tdT uptake
assays, consistent with active degradation of fHA by Hyal1
upon internalization and delivery to acidified vesicles. We then
measured the overall endocytic rate by incubating cells with
fluorescently labeled transferrin, which is a frequently used
reporter of clathrin-dependent internalization rates. Initial
uptake of labeled transferrin occurred in all stable lines after
only 5 min of incubation (Fig. 8B) and increased up to 30 min.
However, the magnitude of signal increase was significantly
higher in cells expressing Hyal1WT-tdT or Hyal1Y202F-tdT
than with either of the lines that lack Hyal1 activity. Thus,
HA homeostasis directly influences the rate of transferrin
uptake in prostate tumor cells, suggesting an overall effect
on endocytic uptake and trafficking in these cells. Moreover,
the increased uptake of HA and transferrin is likely a mechanism by which the tumor cell could acquire and sequester
resources such as carbohydrate and iron that promote the
increased proliferation and motility observed in the Hyal1overexpressing cells.
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FIGURE 7. Secreted Hyal1 is essential for efficient HA internalization. Stable 22Rv1 lines were incubated with fHA without prior treatment (A), immediately
following treatment with brefeldin A (B), or after treatment with brefeldin A followed by a 30-min chase with media to allow recovery (C). In each row,
representative Hyal1WT-tdT cell images are in the left column, Hyal1Y202F-tdT images are in the center column, and Hyal1E131Q-tdT images are on the right.
Inset panels are magnified images of individual cells designated by white squares in the merged panels. The left inset shows the isolated green channel
fluorescence in black and white indicating fHA uptake, and the right inset is the corresponding red channel signal indicating tdT localization. D, number of
green vesicles per cell was determined using ImageJ for at least 10 cells per condition, each repeated three times and compared for statistical significance by
one-way analysis of variance. Error bars indicate S.E. Scale bars, 10 m. NT, no treatment; BFA, brefeldin A; rec, recovery.

Discussion
Invasive prostate cancer is clinically associated with elevation of Hyal1 expression, which predicts biochemical recurrence after resection, and Hyal1 overexpression functionally
MAY 22, 2015 • VOLUME 290 • NUMBER 21

accelerates metastatic progression of orthotopic prostate
tumors in mice by increasing rates of proliferation and migration. Based on our previous findings that the distribution and
signaling of multiple cell surface receptors were altered signifJOURNAL OF BIOLOGICAL CHEMISTRY

13153

Hyaluronidase and Vesicle Trafficking

FIGURE 8. Stable Hyal1 expression increases rates of HA uptake and
transferrin internalization by prostate tumor cells. A, single cell suspensions of 22Rv1 prostate tumor cells stably expressing empty vector (tdT),
Hyal1WT-tdT, Hyal1Y202F-tdT, or Hyal1E131Q-tdT were incubated in serumfree media (negative) or with media containing 100 nM fHA for the indicated
times. HA uptake was monitored via internalized fluorescence intensity using
flow cytometry. B, prostate tumor cells in A were incubated in serum-free
media (negative) or with media containing 2.5 g/ml transferrin-Alexa Fluor
633 for the incubation times indicated, and transferrin uptake was monitored
via internalized fluorescence intensity using flow cytometry. In both panels,
mean fluorescence intensity as plotted is 1000⫻ higher than the value on the
axis for presentation. Data are representative of experiments repeated at
least four times each.

icantly in Hyal1-overexpressing prostate tumor cells, we tested
the hypothesis that intracellular vesicular trafficking was perturbed by excessive catalytic activity of Hyal1. Here, we have
shown that rates of endocytosis for both substrates (e.g. HA)
and non-substrates (e.g. transferrin) are increased by Hyal1
expression and that this effect specifically requires Hyal1 catalytic competence. Moreover, we found that the correct trafficking itinerary of Hyal1 involves its secretion through the canonical ER-Golgi pathway to the extracellular space followed by
endocytosis-mediated reuptake, vesicular sorting within the
cell, and re-externalization of a portion through Rab11-mediated slow recycling with the majority present in Rab5-positive
early endosomes or Rab7-positive late endosomes/lysosomes.
Interestingly, although the catalytic activity of Hyal1 is not
absolutely required for a portion of the Hyal1 to reach the extra-
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cellular space, it is required for its efficient reuptake in vesicles
and for the appreciable uptake of its substrate, HA.
HA homeostasis could be affecting multiple pathways within
the cell directly by influencing the endocytic rate and thereby
affecting the cell’s access to resources internalized in this manner. Elevated internalization of HA has been shown to provide
greater access to sugars that can be shunted through altered
metabolic pathways to produce energy through aerobic glycolysis (24), also accelerating growth of tumor cells by allowing the
partially oxidized carbohydrate skeletons into biosynthetic
pathways. Increased access to amino sugars through this degradation pathway additionally fuels reversible epigenetic modifications such as N-acetylglucosaminylation of histones, which
has broad ranging effects on gene expression and metabolic
repatterning (25, 26).
Transferrin trafficking has similarly been shown to contribute to cell survival and growth promotion in cancer through
elevated provision of iron to iron-dependent protein biosynthesis and redox-regulated antioxidant pathways (27). In fact,
transferrin may have clinical utility in targeting tumor cells with
antiapoptotic agents (28), which our study suggests would be
enhanced in tumors that overexpress Hyal1 and/or by concurrent delivery of Hyal1 through accelerated endocytosis.
In addition to cellular resource-promoted effects, there
could also be specific impacts on cell signaling downstream of
receptor endocytosis. Cell surface receptors that toggle
between the plasma membrane and intracellular vesicles to preserve signaling sensitivity in the presence of continuous ligand
(e.g. EGF receptor; for a review, see Ref. 29) can sustain signaling
even while being a component of the endocytic vesicle. Recycling of integrins via endosomal internalization at the trailing
edge, trafficking through the cell, and re-externalization at the
leading edge is critical for directional cell motility (30 –32). It
was shown that ␤1 integrin recycling during cell migration
occurs in vesicular compartments and is regulated by specific
Rab GTPases (33, 34) that are distinct from the endosome-tolysosome route followed by internalized material being
degraded. Recycling of receptors is determined in part by endosomal pH drop, which differentially dissociates alternate
ligands (33, 35). Differences in signaling activation and/or
intensity may accompany the internalization of receptors, and
this could also influence the proliferation, motility, and other
aggressive properties of the cells. These receptors could be
eventually degraded in lysosomes or recycled back to the cell
surface and available for ligand binding again. The specific fate
of unique cell surface receptors in the context of HA turnover
remains to be elucidated.
An intriguing implication of our study is that internalized
HA appears to have two fates by virtue of its requisite association with Hyal1. A portion of it is clearly directed to complete
lysosomal degradation through a combination of Hyal1 activity,
which yields a tetrasaccharide as its terminal product that is
acted on in lysosomes by exoglycosidases. However, an additional portion has the potential to remain associated with Hyal1
during the sorting to slow recycling vesicles and secreted back
to the extracellular space as Hyal1 is re-externalized (Fig. 9).
This partially processed material could then have increased
affinity for cell surface HA receptors on neighboring cells. Small
VOLUME 290 • NUMBER 21 • MAY 22, 2015
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FIGURE 9. Proposed model for Hyal1 impact on vesicle trafficking and
tumor cell motility. Hyal1 activity is virtually undetectable (basal) in parental
22Rv1 cells, which retain low levels of cell surface high molecular weight (HMW)
HA and are poorly motile. When Hyal1 activity is elevated by overexpression, the
increased secretion of Hyal1 leads to absence of surface high molecular weight
HA; increased motility, proliferation, and receptor recycling; and accelerated
vesicular trafficking that depends on Hyal1 binding to HA and/or chondroitin
sulfate proteoglycans (CSPG) and may result in increased nutrient availability for
biosynthesis as well as the release of partially digested, biologically potent low
molecular weight (LMW) HA signals. EE, early endosome; LE, late endosome; RE,
recycling endosome; PM, plasma membrane.

fragments of HA have been shown to enhance proliferation,
motility, and angiogenesis, and an increase in partial HA catalysis to oligomeric fragments resulting from excess vesicular
Hyal1-mediated uptake could contribute to the enhanced procancer phenotype we see in the Hyal1-overexpressing cells (9).
Several conserved residues within the Hyal1 protein are
important to maintain wild-type activity (19). Specifically,
mutation of residue 131 from glutamate to glutamine abolishes all catalytic activity (19), whereas tyrosine to phenylalanine at position 202 maintains maximal catalytic competence only at saturating substrate concentrations. Expression
of Hyal1E131Q causes cells to have a reduced proliferation rate
and migratory phenotype compared with cells expressing wildtype Hyal1. Utilizing pH-stable fluorescent fusion proteins of
the wild type and catalytic mutants, we see that catalytic activity
of Hyal1 is actually required for proper localization in the cell,
and for the first time, we can visualize its trafficking itinerary
through multiple sorted vesicle compartments. It is apparent
that Hyal1WT and the Y202F mutant are vesicular in cells at
steady state, colocalize with lysosomal tracers and Rab-GFP
fusion constructs, and overlap with endosomal EEA1 and lysosomal cathepsin D in sucrose gradient fractions. In contrast,
Hyal1E131Q-tdT does not have a significant vesicular localization, correlates with the ER network, and overlaps with the ER
marker calnexin in gradient fractions. How the catalytic activity
MAY 22, 2015 • VOLUME 290 • NUMBER 21

can affect the localization of the Hyal1 protein is not clear, but
the partial wild-type behavior of the HA-binding mutant Y202F
in 22Rv1 cells suggests some degree of HA or other substrate
binding is required for constitutive secretion as well as reuptake
(Fig. 9). For example, perhaps the Y202F mutant has an altered
ability to bind chondroitin sulfate proteoglycans and is differentially sensitive to competitive binding of excess HA fragments or HA polymers and therefore does not get internalized
and trafficked similarly. We detect E131Q protein in the conditioned media so at least a portion is being secreted by the cell,
but much of it remains in the ER due to its loss of catalytic
function, which likely includes binding.
Imaging the Hyal1 fusion proteins, we also noticed that vesicles containing wild-type Hyal1 seem to be clustered at the
focal adhesions of cells. There was no apparent trend seen for
the Hyal1E131Q-tdT fusion protein. The creation and diffusion
of focal adhesions are instrumental for cell migration, especially
in a unidirectional manner. It has been shown that inhibiting
HA synthesis in esophageal cancer cell lines causes disruption
of focal adhesions (36). Perhaps it is a combination of HA synthesis and degradation and internalization accompanied by the
Hyals that actually has the most effect on prostate cancer cells.
Finally, we used different chemicals to perturb common
endocytic trafficking mechanisms to see whether localization of
Hyal1 was affected in these situations. Brefeldin A, which
blocks the transport of proteins from ER to Golgi, does not
change the localization of the Hyal1-tdT fusion protein, indicating that it is likely not rapidly turned over. The localization
of the Hyal1E131Q-tdT protein was also similar with and without brefeldin A treatment except for a modest intensification of
the ER signal, supporting its reduced rate of secretion relative to
the wild-type Hyal1. These results are also consistent with ⬇10fold higher expression of Hyal1E131Q-tdT in the cell lysate
compared with that of wild-type Hyal1. We used chloroquine to
prevent the acidification of late endosomes into lysosomes.
Hyal1 is reportedly a lysosomal protein (18) so we are not surprised to see that when we inhibit lysosomal acidification there
is a buildup of Hyal1WT-tdT and Hyal1Y202F-tdT in larger
sized vesicles compared with control treatment. This again suggests that the Hyal1 is ultimately trafficked into lysosomes and
undergoing degradation. However, what is novel is the implication that Hyal1 is trafficked and released back to the plasma
membrane without being degraded, so inhibition of this pathway would also cause buildup of protein within the cell by this
route. Hyal1E131Q-tdT protein is also affected by chloroquine
treatment, which reduces its proteolysis in the cell as well as its
overall levels, suggesting that only newly synthesized protein is
present prior to secretion. We used bafilomycin A1, an inhibitor of vacuolar ATPases, to prevent fusion of autophagosomes
with lysosomes. Treatment of Hyal1WT-tdT cells with bafilomycin A1 induces accumulation of Hyal1 in significantly larger
vesicles that are fewer in number. This indicates that the fusion
of smaller endocytic vesicles and autophagosomes with lysosomes is prevented and that Hyal1 is intriguingly present in
autophagic vesicles, which may be required for engulfment of
HA encapsulated cells.
In summary, we have shown that the catalytic activity of
Hyal1 is required for its effects on enhancement of cell prolifJOURNAL OF BIOLOGICAL CHEMISTRY
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eration and motility. The mechanism involves localization and
trafficking of the protein that are dependent on its association
with HA and/or chondroitin sulfate ligands during secretion. In
addition, the overexpression of wild-type Hyal1 in aggressive
prostate tumor cells increases accumulation of internalized HA
fragments and overall endocytic rate. This is one mechanism by
which accelerated HA turnover influences the presence and
activation of cell surface receptors that control cellular metabolic pathways.
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